Novel Association of Genetic Markers Affecting CYP2A6 Activity and Lung Cancer Risk
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Metabolism of nicotine by cytochrome P450 2A6 (CYP2A6) is a suspected determinant of smoking dose and, consequently, lung cancer risk. We conducted a genome-wide association study (GWAS) of CYP2A6 activity, as measured by the urinary ratio of trans-3′-hydroxycotinine and its glucuronide conjugate over cotinine (total 3HCOT/COT), among 2,239 smokers in the Multiethnic Cohort (MEC) study. We identified 248 CYP2A6 variants associated with CYP2A6 activity (P < 5 × 10−8). CYP2A6 activity was correlated (r = 0.32; P < 0.0001) with total nicotine equivalents (a measure of nicotine uptake). When we examined the effect of these variants on lung cancer risk in the Transdisciplinary Research in Cancer of the Lung (TRICL) consortium GWAS dataset (13,479 cases and 43,218 controls), we found that the vast majority of these individual effects were directionally consistent and associated with an increased lung cancer risk. Two hundred and twenty-six of the 248 variants associated with CYP2A6 activity in the MEC were available in TRICL. Of them, 81% had directionally consistent risk estimates, and six were globally significantly associated with lung cancer. When conditioning on nine known functional variants and two deletions, the top two SNPs (rs56113850 in MEC and rs35755165 in TRICL) remained significantly associated with CYP2A6 activity in MEC and lung cancer in TRICL. The present data support the hypothesis that a greater CYP2A6 activity causes smokers to smoke more extensively and be exposed to higher levels of carcinogens, resulting in an increased risk for lung cancer. Although the variants identified in these studies may be used as risk prediction markers, the exact causal variants remain to be identified. Cancer Res; 76(19); 5768–76. ©2016 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Howie, B. N., Donnelly, P., & Marchini, J. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000529 · Cited by 3,928 · cited 5×
“Poorly imputed SNPs defined by an RSQR 0.30 with MACH1/minimac or an information measure Is 0.40 with IMPUTE2 were excluded from the analyses.”
MethodInfluentialA linear complexity phasing method for thousands of genomes
Delaneau, O., Marchini, J., & Zagury, J.-F. (2012) · Nature Methods · doi:10.1038/nmeth.1785 · Cited by 1,850 · cited 2×
“Imputation of untyped variants included in the 1000 Genomes Project (http://www.1000genomes.org/) was performed using SHAPEIT (20) and IMPUTE2 (21) using a cosmopolitan reference panel (all groups included).”
MethodMaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes
Li, Y., Willer, C. J., Ding, J., Scheet, P., & Abecasis, G. R. (2010) · Genetic Epidemiology · doi:10.1002/gepi.20533 · Cited by 1,843
Fast and accurate genotype imputation in genome-wide association studies through pre-phasing
Howie, B., Fuchsberger, C., Stephens, M., Marchini, J., & Abecasis, G. R. (2012) · Nature Genetics · doi:10.1038/ng.2354 · Cited by 1,737 · cited 1×
“Untyped SNPs were imputed using the IMPUTE2 (21), MACH1 (34) or minimac (35) software and HapMap Phase II, Phase III and/or 1000 Genome Project data release 2010-08 or 2010-06 reference genotypes.”
MethodGenetic Investigation of ANthropometric Traits (GIANT) Consortium, Yang, J., DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium, Ferreira, T., Morris, A. P., Medland, S. E., Madden, P. A. F., Heath, A. C., Martin, N. G., Montgomery, G. W., et al. (2012) · Nature Genetics · doi:10.1038/ng.2213 · Cited by 1,712 · cited 1×
“We performed a similar conditional analysis for lung cancer risk in the TRICL data (using GCTA based on summary statistics (42)) conditioning on each of the”
MethodA variant associated with nicotine dependence, lung cancer and peripheral arterial disease
Thorgeirsson, T. E., Geller, F., Sulem, P., Rafnar, T., Wiste, A., Magnusson, K. P., Manolescu, A., Thorleifsson, G., Stefansson, H., Ingason, A., et al. (2008) · Nature · doi:10.1038/nature06846 · Cited by 1,523 · cited 1×
“1, which includes the nicotinic receptor subunit genes CHRNA5-CHRNA3-CHRNB4, is the strongest susceptibility locus for nicotine dependence and lung cancer (3-5).”
BackgroundAmos, C. I., Wu, X., Broderick, P., Gorlov, I. P., Gu, J., Eisen, T., Dong, Q., Zhang, Q., Gu, X., Vijayakrishnan, J., et al. (2008) · Nature Genetics · doi:10.1038/ng.109 · Cited by 1,310
Self-citationHung, R. J., McKay, J. D., Gaborieau, V., Boffetta, P., Hashibe, M., Zaridze, D., Mukeria, A., Szeszenia-Dabrowska, N., Lissowska, J., Rudnai, P., et al. (2008) · Nature · doi:10.1038/nature06885 · Cited by 1,275 · cited 2×
“The meta-analysis was based on summary data from 19 GWAS undertaken by eight analytic centers providing genotype data on 13,479 patients with lung cancer and 43,218 controls of European descent: the MD Anderson Cancer Center lung cancer study (24); the NCI lung cancer GWAS including the Environment and Genetics in Lun…”
BackgroundMethodSelf-citationGenome partitioning of genetic variation for complex traits using common SNPs
Yang, J., Manolio, T. A., Pasquale, L. R., Boerwinkle, E., Caporaso, N., Cunningham, J. M., de Andrade, M., Feenstra, B., Feingold, E., Hayes, M. G., et al. (2011) · Nature Genetics · doi:10.1038/ng.823 · Cited by 890 · cited 1×
“from this matrix were included in the analysis to adjust for population stratification (22).”
MethodSelf-citationPe'er, I., Yelensky, R., Altshuler, D., & Daly, M. J. (2008) · Genetic Epidemiology · doi:10.1002/gepi.20303 · Cited by 783
Cited by
eQTLGen, Wray, N. R., 23andMe, the Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, Ripke, S., Mattheisen, M., Trzaskowski, M., Byrne, E. M., Abdellaoui, A., Adams, M. J., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0090-3 · Cited by 3,005
ADHD Working Group of the Psychiatric Genomics Consortium (PGC), Demontis, D., Early Lifecourse & Genetic Epidemiology (EAGLE) Consortium, 23andMe Research Team, Walters, R. K., Martin, J., Mattheisen, M., Als, T. D., Agerbo, E., Baldursson, G., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0269-7 · Cited by 2,203
Genome-wide association studies identify 137 genetic loci for DNA methylation biomarkers of aging
McCartney, D. L., Min, J. L., Richmond, R. C., Lu, A. T., Sobczyk, M. K., Davies, G., Broer, L., Guo, X., Jeong, A., Jung, J., et al. (2021) · Genome Biology · doi:10.1186/s13059-021-02398-9 · Cited by 292
Matoba, N., Akiyama, M., Ishigaki, K., Kanai, M., Takahashi, A., Momozawa, Y., Ikegawa, S., Ikeda, M., Iwata, N., Hirata, M., et al. (2019) · Nature Human Behaviour · doi:10.1038/s41562-019-0557-y · Cited by 71
Metadata
- Authors
- Patel, Y. M., Park, S. L., Han, Y., Wilkens, L. R., Bickeböller, H., Rosenberger, A., Caporaso, N., Landi, M. T., Brüske, I., Risch, A., Wei, Y., Christiani, D. C., Brennan, P., Houlston, R., McKay, J., McLaughlin, J., Hung, R., Murphy, S., Stram, D. O., Amos, C., & Le Marchand, L.
- Venue
- Cancer Research
- Published
- 2016-10-01
- Volume
- 76
- Issue
- 19
- Pages
- 5768-5776
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2501176776
- Cited by
- 70
- References
- 10
- FWCI
- 8.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Novel Association of Genetic Markers Affecting CYP2A6 Activity and Lung Cancer Risk. https://app.cochat.ai/papers/10.1158/0008-5472.can-16-0446
- The paper
- Patel, Y. M., Park, S. L., Han, Y., Wilkens, L. R., Bickeböller, H., Rosenberger, A., Caporaso, N., Landi, M. T., Brüske, I., Risch, A., Wei, Y., Christiani, D. C., Brennan, P., Houlston, R., McKay, J., McLaughlin, J., Hung, R., Murphy, S., Stram, D. O., . . . Le Marchand, L. (2016). Novel Association of Genetic Markers Affecting CYP2A6 Activity and Lung Cancer Risk. Cancer Research. https://doi.org/10.1158/0008-5472.can-16-0446
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.